Probiotics in Asthma and Allergy Prevention

Maurizio Mennini1, Lamia Dahdah1, Maria Cristina Artesani1

  • 1Division of Allergy, Bambino Gesù Children's Hospital, Vatican City, Vatican City.

Frontiers in Pediatrics
|August 22, 2017
PubMed

Insights

Probiotics show potential for infant health, but research on their use for preventing food allergies is limited. More evidence is needed before specific recommendations can be made for probiotics in allergy prevention.

Area of Science:

  • Microbiology
  • Immunology
  • Pediatrics

Background:

  • Interest in probiotics for infant health is growing, with research linking infant microbiome alterations to health outcomes.
  • A healthy gut microbiota is crucial for developing immune tolerance, and probiotics may offer protection against diseases.
  • Analyzing gut dysbiosis in food allergy is complex due to varied study designs and methodologies.

Purpose of the Study:

  • To review the current evidence on probiotics and their role in infant health, particularly concerning food allergy.
  • To highlight the challenges in studying probiotics' effects on the infant gut microbiome and immune development.
  • To assess the existing recommendations for probiotic use in allergy prevention and treatment.

Main Methods:

  • Literature review of studies on probiotics, infant microbiome, and immune tolerance.
  • Analysis of interventional studies investigating probiotic effects on disease development.
  • Evaluation of factors complicating dysbiosis analysis in food allergy subjects.

Main Results:

  • While in vitro evidence for probiotics is valid, clinical data supporting their use in allergy and asthma prevention is insufficient.
  • Current scientific societies do not recommend pre- or probiotics for treating food allergies, with prevention use based on limited evidence.
  • Significant heterogeneity exists across studies, hindering direct comparisons and definitive conclusions.

Conclusions:

  • There is insufficient evidence to recommend specific probiotics for preventing allergy and asthma in infants.
  • Further high-quality research is required to establish the efficacy and safety of probiotics in this context.
  • Current recommendations for probiotic use in allergy prevention are based on limited scientific backing.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K